At $2,600 per year, SNY’s Multaq will be one of the most expensive pills for a chronic common disease: <a href="http://www.reuters.com/article/marketsNews/idINLS59493520090728" rel="nofollow" target="_blank">http://www.reuters.com/article/marketsNews/idINLS59493520090728</a>